Bristol Reports Strong 2008 Earnings But Sharp Patent Cliffs Loom

Analysts question whether firm’s “string of pearls” growth strategy can offset patent hit.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet